Science and Research

Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria

Inborn errors of human IFN-γ-dependent macrophagic immunity underlie mycobacterial diseases, whereas inborn errors of IFN-α/β-dependent intrinsic immunity underlie viral diseases. Both types of IFNs induce the transcription factor IRF1. We describe unrelated children with inherited complete IRF1 deficiency and early-onset, multiple, life-threatening diseases caused by weakly virulent mycobacteria and related intramacrophagic pathogens. These children have no history of severe viral disease, despite exposure to many viruses, including SARS-CoV-2, which is life-threatening in individuals with impaired IFN-α/β immunity. In leukocytes or fibroblasts stimulated in vitro, IRF1-dependent responses to IFN-γ are, both quantitatively and qualitatively, much stronger than those to IFN-α/β. Moreover, IRF1-deficient mononuclear phagocytes do not control mycobacteria and related pathogens normally when stimulated with IFN-γ. By contrast, IFN-α/β-dependent intrinsic immunity to nine viruses, including SARS-CoV-2, is almost normal in IRF1-deficient fibroblasts. Human IRF1 is essential for IFN-γ-dependent macrophagic immunity to mycobacteria, but largely redundant for IFN-α/β-dependent antiviral immunity.

  • Rosain, J.
  • Neehus, A. L.
  • Manry, J.
  • Yang, R.
  • Le Pen, J.
  • Daher, W.
  • Liu, Z.
  • Chan, Y. H.
  • Tahuil, N.
  • Türel, Ö
  • Bourgey, M.
  • Ogishi, M.
  • Doisne, J. M.
  • Izquierdo, H. M.
  • Shirasaki, T.
  • Le Voyer, T.
  • Guérin, A.
  • Bastard, P.
  • Moncada-Vélez, M.
  • Han, J. E.
  • Khan, T.
  • Rapaport, F.
  • Hong, S. H.
  • Cheung, A.
  • Haake, K.
  • Mindt, B. C.
  • Pérez, L.
  • Philippot, Q.
  • Lee, D.
  • Zhang, P.
  • Rinchai, D.
  • Al Ali, F.
  • Ahmad Ata, M. M.
  • Rahman, M.
  • Peel, J. N.
  • Heissel, S.
  • Molina, H.
  • Kendir-Demirkol, Y.
  • Bailey, R.
  • Zhao, S.
  • Bohlen, J.
  • Mancini, M.
  • Seeleuthner, Y.
  • Roelens, M.
  • Lorenzo, L.
  • Soudée, C.
  • Paz, M. E. J.
  • González, M. L.
  • Jeljeli, M.
  • Soulier, J.
  • Romana, S.
  • L'Honneur, A. S.
  • Materna, M.
  • Martínez-Barricarte, R.
  • Pochon, M.
  • Oleaga-Quintas, C.
  • Michev, A.
  • Migaud, M.
  • Lévy, R.
  • Alyanakian, M. A.
  • Rozenberg, F.
  • Croft, C. A.
  • Vogt, G.
  • Emile, J. F.
  • Kremer, L.
  • Ma, C. S.
  • Fritz, J. H.
  • Lemon, S. M.
  • Spaan, A. N.
  • Manel, N.
  • Abel, L.
  • MacDonald, M. R.
  • Boisson-Dupuis, S.
  • Marr, N.
  • Tangye, S. G.
  • Di Santo, J. P.
  • Zhang, Q.
  • Zhang, S. Y.
  • Rice, C. M.
  • Béziat, V.
  • Lachmann, N.
  • Langlais, D.
  • Casanova, J. L.
  • Gros, P.
  • Bustamante, J.

Keywords

  • Child
  • Humans
  • Interferon-gamma
  • *covid-19
  • SARS-CoV-2
  • Interferon-alpha
  • *Mycobacterium
  • Interferon Regulatory Factor-1
  • Irf1
  • Mycobacterium
  • inborn errors of immunity
  • interferon-stimulated gene
  • interferon-γ
  • macrophages
  • viruses
Publication details
DOI: 10.1016/j.cell.2022.12.038
Journal: Cell
Pages: 621-645.e33 
Number: 3
Work Type: Original
Location: BREATH
Disease Area: PALI
Partner / Member: MHH
Access-Number: 36736301

DZL Engagements

chevron-down